Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
A4079 Fosinopril sodiumSummary: ACE inhibitor
-
A4082 Olmesartan medoxomilSummary: AT1 receptor antagonist
-
B2204 Enalaprilat DihydrateSummary: angiotensin-converting enzyme (ACE) inhibitor
-
B2208 RamiprilSummary: angiotensin-converting enzyme (ACE) inhibitor
-
A4409 SpinorphinSummary: P2X3 receptors against
-
C3492 RamiprilatSummary: angiotensin-converting enzyme inhibitor
-
C3931 ResorcinolnaphthaleinSummary: ACE2 activator
-
B3468 Zofenopril calciumSummary: angiotensin converting enzyme (ACE) inhibitor
-
B3540 TrandolaprilSummary: angiotensin-converting enzyme (ACE) inhibitor